Bulletin
Investor Alert

Company Close Updates

Aug. 17, 2022, 4:31 p.m. EDT

Moderna Inc. stock falls Wednesday, underperforms market

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) slid 5.93% to $158.00 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) falling 1.25% to 12,938.12 and Dow Jones Industrial Average (DOW:DJIA) falling 0.50% to 33,980.32. This was the stock's second consecutive day of losses. Moderna Inc. closed $306.85 below its 52-week high ($464.85), which the company reached on September 10th.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (NYS:ABBV) fell 0.78% to $141.44, Amgen Inc. (NAS:AMGN) fell 0.25% to $250.58, and AstraZeneca PLC ADR (NAS:AZN) fell 0.48% to $66.42. Trading volume (5.4 M) eclipsed its 50-day average volume of 5.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.